Bi Asset Management Fondsmaeglerselskab A Biogen Inc. Transaction History

Bi Asset Management Fondsmaeglerselskab A

$10.2 Billion
Q2 2025

A detailed history of Bi Asset Management Fondsmaeglerselskab A transactions in Biogen Inc. stock. As of the latest transaction made, Bi Asset Management Fondsmaeglerselskab A holds 6,626 shares of BIIB stock, worth $991,315. This represents 0.01% of its overall portfolio holdings.

Number of Shares

6,626

Previous 5,285 25.37%

Holding current value

$991,315

Previous $723,000 15.08%

% of portfolio

0.01%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$113.38 - $135.49 $152,042 - $181,692	1,341 Added 25.37%	6,626 $832,000
Q1 2025 May 14, 2025	SELL	$133.43 - $153.27 $177,328 - $203,695	-1,329 Reduced 20.09%	5,285 $723,000
Q4 2024 Feb 13, 2025	SELL	$146.47 - $191.55 $81,583 - $106,693	-557 Reduced 7.77%	6,614 $1.01 Million
Q3 2024 Nov 13, 2024	BUY	$189.07 - $236.8 $241,442 - $302,393	1,277 Added 21.67%	7,171 $1.39 Million
Q2 2024 Aug 14, 2024	BUY	$190.52 - $236.72 $73,350 - $91,137	385 Added 6.99%	5,894 $1.37 Million
Q1 2024 May 03, 2024	SELL	$212.02 - $267.71 $53,853 - $67,998	-254 Reduced 4.41%	5,509 $1.19 Million
Q4 2023 Feb 09, 2024	SELL	$222.59 - $267.94 $170,058 - $204,706	-764 Reduced 11.71%	5,763 $1.49 Million
Q3 2023 Nov 13, 2023	SELL	$253.3 - $285.89 $306,493 - $345,926	-1,210 Reduced 15.64%	6,527 $1.68 Million
Q2 2023 Aug 03, 2023	BUY	$275.25 - $318.06 $456,364 - $527,343	1,658 Added 27.27%	7,737 $2.2 Million
Q1 2023 May 12, 2023	BUY	$256.56 - $292.34 $559,044 - $637,008	2,179 Added 55.87%	6,079 $1.69 Million
Q4 2022 Feb 13, 2023	BUY	$252.44 - $306.72 $692,947 - $841,946	2,745 Added 237.66%	3,900 $1.08 Million
Q3 2022 Nov 07, 2022	BUY	$194.69 - $268.46 $147,964 - $204,029	760 Added 192.41%	1,155 $308,000
Q2 2022 Aug 12, 2022	BUY	$187.54 - $223.02 $74,078 - $88,092	395 New	395 $81,000
Q1 2022 May 11, 2022	SELL	$193.77 - $244.14 $440,051 - $554,441	-2,271 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$282.99 - $369.05 $243,937 - $318,121	-862 Reduced 27.51%	2,271 $643,000
Q1 2021 May 10, 2021	SELL	$242.95 - $284.63 $4.32 Million - $5.06 Million	-17,790 Reduced 85.03%	3,133 $876,000
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $5.98 Million - $9 Million	-25,317 Reduced 54.75%	20,923 $5.12 Million
Q3 2020 Nov 09, 2020	BUY	$264.77 - $305.71 $1.71 Million - $1.98 Million	6,461 Added 16.24%	46,240 $13.1 Million
Q2 2020 Aug 05, 2020	BUY	$258.66 - $342.55 $5.82 Million - $7.71 Million	22,511 Added 130.36%	39,779 $10.6 Million
Q1 2020 May 11, 2020	BUY	$268.85 - $341.04 $520,493 - $660,253	1,936 Added 12.63%	17,268 $5.46 Million
Q4 2019 Mar 19, 2020	SELL	$220.06 - $304.07 $2.19 Million - $3.02 Million	-9,938 Reduced 39.33%	15,332 $4.55 Million
Q3 2019 Mar 19, 2020	BUY	$217.44 - $243.88 $4.54 Million - $5.09 Million	20,870 Added 474.32%	25,270 $5.88 Million
Q2 2019 Mar 19, 2020	BUY	$219.29 - $241.72 $964,876 - $1.06 Million	4,400 New	4,400 $1.03 Million

Others Institutions Holding BIIB

# of Institutions

1,038

Shares Held

131M

Call Options Held

2.84M

Put Options Held

2.54M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bi Asset Management Fondsmaeglerselskab A, based on Form 13F filings with the SEC.

News

Stay updated on Bi Asset Management Fondsmaeglerselskab A with notifications on news.

Account

Bi Asset Management Fondsmaeglerselskab A Biogen Inc. Transaction History